Geriatric Population to drive the Global Alzheimer’s Disease Therapeutics and Diagnostics Market

 Breaking News
  • No posts were found

Geriatric Population to drive the Global Alzheimer’s Disease Therapeutics and Diagnostics Market

December 21
16:12 2021
Geriatric Population to drive the Global Alzheimer’s Disease Therapeutics and Diagnostics Market
AD Therapeutics and Diagnostics Market
According to a new market research report launched by Inkwood Research, the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is set to progress at a CAGR of 5.40% during the forecast period 2021-2028. The market is also anticipated to garner revenue worth $9979.0 million by 2028.

According to a new market research report launched by Inkwood Research, the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is set to progress at a CAGR of 5.40% during the forecast period 2021-2028. The market is also anticipated to garner revenue worth $9979.0 million by 2028. 

Browse 51 market data Tables and 46 Figures spread over 225 Pages, along with in-depth analysis on the Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Therapeutics and Diagnostics & by Geography. 

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain. 

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Scenario

Globally, a large number of older adults have Alzheimer’s disease, which gradually damages their memory and other skills. Moreover, it is among the major reason for dementia among the older population. This has further increased the need for therapeutics and diagnostics measures. As per the World Population Prospects 2019, one in six people will be over 65 years by 2050. Thus, the number of geriatric people is estimated to double by 2050. This rise in the geriatric population is expected to increase the incidence rate of Alzheimer’s disease, thereby boosting the studied market’s growth. 

However, the lack of surrogate markers significantly impacts the global market’s growth. This can impede the drug discovery and development process to a large extent. Besides, the early diagnosis of the disease is challenging as the initial symptoms are usually overlooked as they are mild. In such as scenario, any diagnostic and therapeutic care cannot be given to a patient, thereby negatively impacting the global market. 

The Global Alzheimer’s Disease Therapeutics and Diagnostics Market report provides data tables and includes charts and graphs for visual analysis.

Request Free Sample Report for Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Therapeutics and Diagnostics & by Geography: https://www.inkwoodresearch.com/reports/alzheimers-disease-therapeutics-and-diagnostics-market/#request-free-sample 

 

Market Segmentation

Market by Therapeutics and Diagnostics         

  • Therapeutics 
  • Therapeutics by Drugs 
  • Marketed Drugs
  • Pipeline Drugs
  • Therapeutics by Disease Stage 
  • Late Stage: Severe Ad
  • Early/Middle Stage: Mild to Moderate Ad
  • Prodromal Stage
  • Therapeutics by Generic and Branded 
  • Branded
  • Generic
  • Diagnostics 
  • Lumbar Puncture Test
  • Positron Emission Tomography
  • Electroencephalography
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Blood Test
  • Other Diagnostics

 

Report Highlights

– The report provides a detailed analysis of the current and future market trends to identify the investment opportunities- Market forecasts till 2028, using estimated market values as the base numbers- Key market trends across the business segments, regions, and countries- Key developments and strategies observed in the market- Market dynamics such as drivers, restraints, opportunities, and other trends- In-depth company profiles of key players and upcoming prominent players- Growth prospects among the emerging nations through 2028

 

Companies Profiled

  • ALLERGAN PLC (ACQUIRED BY ABBVIE)
  • AMARANTUS BIOSCIENCE HOLDINGS INC
  • BAXTER INTERNATIONAL INC
  • BIOGEN INC
  • COGNOPTIX INC
  • EISAI CO LTD
  • ELI LILLY & COMPANY
  • HOFFMANN-LA ROCHE
  • GE HEALTHCARE
  • JOHNSON & JOHNSON
  • LUPIN LIMITED
  • MERCK & CO INC
  • NOVARTIS AG
  • PFIZER INC
  • SIEMENS HEALTHINEERS AG
  • SUN PHARMACEUTICALS INDUSTRIES LTD
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • ZYDUS CADILA

 

Related Reports

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET – The global kidney cancer therapeutics and diagnostics market is likely to register growth at a CAGR of 5.52% over the forecasted period 2019 to 2028. 

GLOBAL STEM CELL MARKET – The global market for stem cell is expected to display a growth rate of 7.82% during the forecasted years 2021-2028. 

GLOBAL NEUROREHABILITATION DEVICE MARKET – The global neurorehabilitation device market is set to grow at a CAGR of 15.12% during the forecasting years 2021-2028. 

Media Contact
Company Name: Inkwood Research
Contact Person: Arvind Iyer
Email: Send Email
Phone: 1-(857) 293-0150
Country: United States
Website: https://www.inkwoodresearch.com/

Related Articles

Calendar

January 2022
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Categories